Brussels, Belgium | Xinhua | The European Commission on Monday granted conditional marketing authorization for Nuvaxovid, the fifth COVID-19 vaccine authorized in the European Union (EU). The authorization of the vaccine, developed by Novavax, followed a scientific recommendation based on an assessment of the safety, effectiveness and quality of the vaccine …
Read More »